Ixabepilone and SBRT For Metastatic Breast Cancer

Phase 2 Withdrawn University of Texas Southwestern Medical Center

NaSingle-groupOpen-labelTreatment

Summary

This study is being done to find the effect of Stereotactic body radiation therapy (SBRT) in combination with Ixabepilone for women with triple negative metastatic breast cancer.

Timeline

Start: 2013-08
Primary completion: 2015-04
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ixabepilone	Small molecule	—	Other

Ixabepilone and SBRT For Metastatic Breast Cancer

Summary

Timeline

Drugs

Indications